Work

Abstract B56: A phase I trial of the combination of dasatinib and lapatinib

Year: 2009

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-09-b56

Authors: Charles Erlichman, Michael E. Menefee, Donald W. Northfelt, Rui Qin, Joel M. Reid, Wilma L. Lingle, Merry Jo Oursler, Monica M. Reinholz, Julian R. Molina, Mitesh J. Borad

Institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic in Arizona

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2080188186

Cites:

Cited by: 1

Related to: 10